Improvements in Physical Function and Pain Relief Were Sustained in Rheumatoid Arthritis Patients Treated for 2 Years with Certolizumab Pegol

被引：0
|
作者：
Bykerk, Vivian [1 ]
Mease, Philip [2 ]
Coteur, Geoffroy
Keininger, Dorothy
机构：
[1] Mt Sinai Hosp, Toronto, ON, Canada
[2] Seattle Rheumatol Associates, Seattle, WA USA
来源：
JOURNAL OF RHEUMATOLOGY | 2009年 / 36卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19
引用
收藏
页码：2567 / 2567
页数：1
相关论文
共 50 条
  • [41] Improvement in Disease Activity and the Long-Term Risk of Serious Infectious Events in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
    Curtis, Jeffrey R.
    de Longueville, Marc
    O'Brien, Cathy
    Haraoui, Boulos
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial
    Keystone, Edward C.
    Combe, Bernard
    Smolen, Josef
    Strand, Vibeke
    Goel, Niti
    van Vollenhoven, Ronald
    Mease, Philip
    Landewe, Robert
    Fleischmann, Roy
    Luijtens, Kristel
    van der Heijde, Desiree
    RHEUMATOLOGY, 2012, 51 (09) : 1628 - 1638
  • [43] Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate
    Maini, RN
    Breedveld, FC
    Kalden, JR
    Smolen, JS
    Furst, D
    Weisman, MH
    St Clair, EW
    Keenan, GF
    van der Heijde, D
    Marsters, PA
    Lipsky, PE
    ARTHRITIS AND RHEUMATISM, 2004, 50 (04): : 1051 - 1065
  • [44] Abatacept provides sustained improvements in pain, fatigue and sleep quality through 2 years in the treatment of rheumatoid arthritis patients in the AIM and ATTAIN trials.
    Dougados, M.
    Russell, A.
    Li, T.
    Sherrer, Y.
    Teng, J.
    McCann, T.
    Westhovens, R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S245 - S246
  • [45] Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
    Kivitz, Alan J.
    Schechtman, Joy
    Texter, Michele
    Fichtner, Andreas
    de Longueville, Marc
    Chartash, Elliot K.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 648 - 657
  • [46] Maintenance of Improvements in Patients' Physical Function, Workplace and Household Productivity, and Reduction in Caregiver Burden with 2 Years of Certolizumab Pegol Treatment in DMARD-Naive, Early RA Patients with Severe Progressive Disease
    Bingham, Clifton, III
    Emery, Paul
    Weinblatt, Michael
    Burmester, Gerd-Rudiger
    Furst, Daniel E.
    Mariette, Xavier
    van Vollenhoven, Ronald
    VanLunen, Brenda
    Purcaru, Oana
    Bykerk, Vivian P.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [47] In patients with rheumatoid arthritis treated with the anti-TNF certolizumab pegol or infliximab, antibodies produced do not cross react with other reagents
    Vetterlein, O.
    Kopotsha, T.
    Nesbitt, A.
    Brown, D.
    Stephens, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 161 - 161
  • [48] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Vivian P. Bykerk
    Peter Nash
    David Nicholls
    Yoshiya Tanaka
    Kevin Winthrop
    Christina Popova
    Nicola Tilt
    Derek Haaland
    Rheumatology and Therapy, 2023, 10 : 693 - 706
  • [49] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Bykerk, Vivian P. P.
    Nash, Peter
    Nicholls, David
    Tanaka, Yoshiya
    Winthrop, Kevin
    Popova, Christina
    Tilt, Nicola
    Haaland, Derek
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 693 - 706
  • [50] IMPROVEMENTS IN JOINT OUTCOMES OF PSORIATIC ARTHRITIS OVER 4 YEARS OF TREATMENT WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AND WITHOUT PRIOR ANTI-TNF EXPOSURE
    Mease, P. J.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Gladman, D.
    Hoepken, B.
    Peterson, L.
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 609 - 609
12345